Analysts predict that Integer Holdings Co. (NYSE:ITGR) will post earnings of $0.77 per share for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Integer’s earnings, with estimates ranging from $0.69 to $0.81. Integer posted earnings of $0.87 per share during the same quarter last year, which would suggest a negative year over year growth rate of 11.5%. The firm is expected to report its next quarterly earnings results on Monday, February 26th.
On average, analysts expect that Integer will report full-year earnings of $2.62 per share for the current financial year, with EPS estimates ranging from $2.55 to $2.65. For the next financial year, analysts forecast that the company will report earnings of $3.18 per share, with EPS estimates ranging from $2.87 to $3.45. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that follow Integer.
Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $0.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.04. The firm had revenue of $363.31 million during the quarter, compared to analysts’ expectations of $354.83 million. Integer had a return on equity of 11.22% and a net margin of 1.42%. The business’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.83 earnings per share.
ITGR has been the subject of a number of research reports. Royal Bank of Canada reissued a “hold” rating and set a $40.00 price objective on shares of Integer in a research report on Friday, September 22nd. BidaskClub raised Integer from a “buy” rating to a “strong-buy” rating in a research report on Thursday, September 28th. TheStreet raised Integer from a “c+” rating to a “b-” rating in a research report on Wednesday, October 18th. Northcoast Research cut Integer from a “buy” rating to a “neutral” rating in a research report on Monday, October 23rd. They noted that the move was a valuation call. Finally, Zacks Investment Research raised Integer from a “sell” rating to a “buy” rating and set a $51.00 price objective for the company in a research report on Wednesday, December 27th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Integer currently has an average rating of “Hold” and an average target price of $51.00.
In other Integer news, VP Thomas J. Mazza sold 23,123 shares of the business’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $46.16, for a total value of $1,067,357.68. Following the completion of the sale, the vice president now owns 26,123 shares of the company’s stock, valued at $1,205,837.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Bill R. Sanford sold 20,605 shares of the business’s stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $46.00, for a total value of $947,830.00. Following the completion of the sale, the director now directly owns 63,606 shares of the company’s stock, valued at approximately $2,925,876. The disclosure for this sale can be found here. Insiders sold 100,625 shares of company stock valued at $4,694,219 in the last ninety days. Insiders own 4.80% of the company’s stock.
Several large investors have recently made changes to their positions in ITGR. Schwab Charles Investment Management Inc. increased its stake in shares of Integer by 28.9% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 192,884 shares of the medical equipment provider’s stock worth $8,738,000 after purchasing an additional 43,214 shares during the period. Bank of Montreal Can increased its stake in shares of Integer by 52.6% in the fourth quarter. Bank of Montreal Can now owns 66,839 shares of the medical equipment provider’s stock worth $3,028,000 after purchasing an additional 23,026 shares during the period. Convergence Investment Partners LLC increased its stake in Integer by 11.1% during the fourth quarter. Convergence Investment Partners LLC now owns 34,935 shares of the medical equipment provider’s stock valued at $1,583,000 after acquiring an additional 3,490 shares during the period. AXA bought a new position in Integer during the third quarter valued at about $5,749,000. Finally, GSA Capital Partners LLP increased its stake in Integer by 83.8% during the third quarter. GSA Capital Partners LLP now owns 42,250 shares of the medical equipment provider’s stock valued at $2,161,000 after acquiring an additional 19,260 shares during the period. 95.02% of the stock is owned by institutional investors.
Integer (ITGR) traded up $1.15 on Friday, reaching $49.05. The company had a trading volume of 116,359 shares, compared to its average volume of 101,519. The firm has a market capitalization of $1,516.98, a PE ratio of 77.86, a price-to-earnings-growth ratio of 1.00 and a beta of 1.08. Integer has a 52-week low of $29.40 and a 52-week high of $55.20. The company has a current ratio of 2.58, a quick ratio of 1.37 and a debt-to-equity ratio of 1.95.
TRADEMARK VIOLATION WARNING: This article was originally published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://www.truebluetribune.com/2018/01/20/integer-holdings-co-itgr-expected-to-announce-earnings-of-0-77-per-share.html.
Integer Company Profile
Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.